Log in

Enanta Pharmaceuticals News Headlines (NASDAQ:ENTA)

$53.20
-0.12 (-0.23 %)
(As of 02/23/2020 04:00 PM ET)
Today's Range
$52.76
Now: $53.20
$54.53
50-Day Range
$51.54
MA: $55.89
$61.95
52-Week Range
$51.00
Now: $53.20
$106.80
Volume210,519 shs
Average Volume185,466 shs
Market Capitalization$1.06 billion
P/E Ratio32.84
Dividend YieldN/A
Beta0.85

Headlines

Enanta Pharmaceuticals (NASDAQ ENTA) News Headlines

Source:
DateHeadline
NASH: The Second WaveNASH: The Second Wave
seekingalpha.com - February 20 at 6:54 PM
Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Receives Consensus Recommendation of "Hold" from AnalystsEnanta Pharmaceuticals Inc (NASDAQ:ENTA) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - February 16 at 11:03 AM
 Brokerages Anticipate Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Will Post Quarterly Sales of $30.66 Million Brokerages Anticipate Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Will Post Quarterly Sales of $30.66 Million
www.americanbankingnews.com - February 14 at 3:42 AM
Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Expected to Post Q2 2020 Earnings of ($0.83) Per ShareEnanta Pharmaceuticals Inc (NASDAQ:ENTA) Expected to Post Q2 2020 Earnings of ($0.83) Per Share
www.americanbankingnews.com - February 13 at 9:20 AM
-$0.63 Earnings Per Share Expected for Enanta Pharmaceuticals Inc (NASDAQ:ENTA) This Quarter-$0.63 Earnings Per Share Expected for Enanta Pharmaceuticals Inc (NASDAQ:ENTA) This Quarter
www.americanbankingnews.com - February 12 at 4:27 AM
Edited Transcript of ENTA earnings conference call or presentation 6-Feb-20 9:30pm GMTEdited Transcript of ENTA earnings conference call or presentation 6-Feb-20 9:30pm GMT
finance.yahoo.com - February 10 at 2:26 PM
Enanta Pharmaceuticals (NASDAQ:ENTA) Releases  Earnings ResultsEnanta Pharmaceuticals (NASDAQ:ENTA) Releases Earnings Results
www.americanbankingnews.com - February 7 at 7:03 PM
Enanta Pharmaceuticals, Inc. (ENTA) CEO Dr. Jay Luly on Q1 2020 Results - Earnings Call TranscriptEnanta Pharmaceuticals, Inc. (ENTA) CEO Dr. Jay Luly on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - February 6 at 10:43 PM
Enanta Pharmaceuticals Inc (ENTA) Q1 2020 Earnings Call TranscriptEnanta Pharmaceuticals Inc (ENTA) Q1 2020 Earnings Call Transcript
www.fool.com - February 6 at 10:43 PM
Enanta Pharmaceuticals (ENTA) Q1 Earnings Top EstimatesEnanta Pharmaceuticals (ENTA) Q1 Earnings Top Estimates
finance.yahoo.com - February 6 at 10:43 PM
Enanta Pharma EPS beats by $0.09, misses on revenueEnanta Pharma EPS beats by $0.09, misses on revenue
seekingalpha.com - February 6 at 5:43 PM
Enanta Pharmaceuticals, Inc. to Host Earnings CallEnanta Pharmaceuticals, Inc. to Host Earnings Call
finance.yahoo.com - February 6 at 5:43 PM
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter and Three Months Ended December 31, 2019Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter and Three Months Ended December 31, 2019
finance.yahoo.com - February 6 at 5:43 PM
Enanta Pharma Q1 2020 Earnings PreviewEnanta Pharma Q1 2020 Earnings Preview
seekingalpha.com - February 5 at 7:31 PM
Is Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) High P/E Ratio A Problem For Investors?Is Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) High P/E Ratio A Problem For Investors?
finance.yahoo.com - February 3 at 8:51 AM
Oppenheimer Weighs in on Enanta Pharmaceuticals Incs FY2020 Earnings (NASDAQ:ENTA)Oppenheimer Weighs in on Enanta Pharmaceuticals Inc's FY2020 Earnings (NASDAQ:ENTA)
www.americanbankingnews.com - February 3 at 6:59 AM
Brokers Offer Predictions for Enanta Pharmaceuticals Incs Q1 2020 Earnings (NASDAQ:ENTA)Brokers Offer Predictions for Enanta Pharmaceuticals Inc's Q1 2020 Earnings (NASDAQ:ENTA)
www.americanbankingnews.com - January 31 at 9:49 AM
Earnings Preview: Enanta Pharmaceuticals (ENTA) Q1 Earnings Expected to DeclineEarnings Preview: Enanta Pharmaceuticals (ENTA) Q1 Earnings Expected to Decline
finance.yahoo.com - January 30 at 2:30 PM
Enanta Pharmaceuticals (ENTA) Set to Announce Quarterly Earnings on ThursdayEnanta Pharmaceuticals (ENTA) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - January 30 at 2:50 AM
Enanta to Host Conference Call on February 6 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal First Quarter Ended December 31, 2019Enanta to Host Conference Call on February 6 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal First Quarter Ended December 31, 2019
finance.yahoo.com - January 24 at 8:35 AM
Enanta Pharma (ENTA) Presents At 38th Annual J.P. Morgan Healthcare Conference - SlideshowEnanta Pharma (ENTA) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - January 14 at 5:15 PM
AbbVies MAVIRET® now listed on the Newfoundland and Labrador formularyAbbVie's MAVIRET® now listed on the Newfoundland and Labrador formulary
finance.yahoo.com - January 14 at 6:53 AM
Enanta Pharmaceuticals Becomes Oversold (ENTA)Enanta Pharmaceuticals Becomes Oversold (ENTA)
www.nasdaq.com - January 14 at 1:53 AM
Enanta to provide R&D and business update for 2020 during annual JPM conferenceEnanta to provide R&D and business update for 2020 during annual JPM conference
seekingalpha.com - January 9 at 2:18 PM
Enanta to Provide Updates on its R&D Programs and Business Outlook for 2020 during the 38th Annual J.P. Morgan Healthcare ConferenceEnanta to Provide Updates on its R&D Programs and Business Outlook for 2020 during the 38th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 9 at 2:18 PM
Does This Valuation Of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Imply Investors Are Overpaying?Does This Valuation Of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Imply Investors Are Overpaying?
finance.yahoo.com - January 4 at 1:54 PM
Enanta Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare ConferenceEnanta Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 30 at 3:56 PM
Is Enanta Pharmaceuticals Inc (ENTA) A Good Stock To Buy?Is Enanta Pharmaceuticals Inc (ENTA) A Good Stock To Buy?
finance.yahoo.com - December 11 at 12:56 PM
Should You Worry About Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) CEO Pay Cheque?Should You Worry About Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) CEO Pay Cheque?
finance.yahoo.com - December 9 at 12:18 PM
Edited Transcript of ENTA earnings conference call or presentation 21-Nov-19 9:30pm GMTEdited Transcript of ENTA earnings conference call or presentation 21-Nov-19 9:30pm GMT
finance.yahoo.com - November 26 at 9:19 PM
Enanta Pharmaceuticals Q4 Results Pulled Down by AbbVies Sinking HCV SalesEnanta Pharmaceuticals' Q4 Results Pulled Down by AbbVie's Sinking HCV Sales
www.nasdaq.com - November 22 at 6:18 AM
Enanta Pharmaceuticals Inc (ENTA) Q4 2019 Earnings Call TranscriptEnanta Pharmaceuticals Inc (ENTA) Q4 2019 Earnings Call Transcript
www.fool.com - November 21 at 10:08 PM
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2019Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2019
finance.yahoo.com - November 21 at 6:55 PM
Enanta Pharmaceuticals (ENTA) Lags Q4 Earnings and Revenue EstimatesEnanta Pharmaceuticals (ENTA) Lags Q4 Earnings and Revenue Estimates
finance.yahoo.com - November 21 at 6:55 PM
Enanta Pharmaceuticals, Inc. Common Stock (ENTA) Earnings Report DateEnanta Pharmaceuticals, Inc. Common Stock (ENTA) Earnings Report Date
www.nasdaq.com - November 20 at 11:33 PM
Enanta Pharma Q3 2019 Earnings PreviewEnanta Pharma Q3 2019 Earnings Preview
seekingalpha.com - November 20 at 6:31 PM
Commit To Buy Enanta Pharmaceuticals At $55, Earn 16.5% Annualized Using OptionsCommit To Buy Enanta Pharmaceuticals At $55, Earn 16.5% Annualized Using Options
www.nasdaq.com - November 20 at 1:31 PM
Is Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) 14% ROE Worse Than Average?Is Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) 14% ROE Worse Than Average?
finance.yahoo.com - November 11 at 1:41 PM
Enanta Pharmaceuticals Announces Poster Presentations at The Liver Meeting® 2019Enanta Pharmaceuticals Announces Poster Presentations at The Liver Meeting® 2019
finance.yahoo.com - November 11 at 8:40 AM
Enanta Pharmaceuticals (ENTA) Presents At Wolfe Research Healthcare Conference - SlideshowEnanta Pharmaceuticals (ENTA) Presents At Wolfe Research Healthcare Conference - Slideshow
seekingalpha.com - November 7 at 10:18 PM
Enanta Pharmaceuticals to Host Conference Call on November 21 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2019Enanta Pharmaceuticals to Host Conference Call on November 21 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2019
finance.yahoo.com - November 5 at 6:34 PM
Enanta Pharmaceuticals to Present at the 2019 Wolfe Research Healthcare ConferenceEnanta Pharmaceuticals to Present at the 2019 Wolfe Research Healthcare Conference
finance.yahoo.com - October 21 at 6:06 PM
Is Enanta Pharmaceuticalss (NASDAQ:ENTA) Share Price Gain Of 145% Well Earned?Is Enanta Pharmaceuticals's (NASDAQ:ENTA) Share Price Gain Of 145% Well Earned?
finance.yahoo.com - October 12 at 10:21 PM
Is Enanta Pharmaceuticals's (NASDAQ:ENTA) Share Price Gain Of 145% Well Earned?Is Enanta Pharmaceuticals's (NASDAQ:ENTA) Share Price Gain Of 145% Well Earned?
finance.yahoo.com - October 12 at 12:19 PM
New Data from Enanta’s Phase 2a Human Challenge Study of EDP-938 for RSV Demonstrates Highly Statistically Significant Reductions (p<0.001) in Total Symptom Score, Mucus Weight and RSV Viral Load as Measured by RT-PCR Assay and by Plaque AssayNew Data from Enanta’s Phase 2a Human Challenge Study of EDP-938 for RSV Demonstrates Highly Statistically Significant Reductions (p<0.001) in Total Symptom Score, Mucus Weight and RSV Viral Load as Measured by RT-PCR Assay and by Plaque Assay
finance.yahoo.com - October 3 at 9:21 AM
Enantas Stock Down Despite NASH Drug Meeting Goal in StudyEnanta's Stock Down Despite NASH Drug Meeting Goal in Study
finance.yahoo.com - September 27 at 9:26 PM
21 Healthcare Stocks Moving In Thursdays Pre-Market Session21 Healthcare Stocks Moving In Thursday's Pre-Market Session
www.msn.com - September 27 at 9:26 PM
Is Enanta Pharma in Trouble Despite Positive Results?Is Enanta Pharma in Trouble Despite Positive Results?
247wallst.com - September 26 at 4:56 PM
Enanta Pharma NASH candidate successful in mid-stage study; shares up 1% after hoursEnanta Pharma NASH candidate successful in mid-stage study; shares up 1% after hours
seekingalpha.com - September 25 at 8:42 PM
Enanta Announces Positive Results of ARGON-1 Study of its lead FXR Agonist, EDP-305, for the Treatment of NASHEnanta Announces Positive Results of ARGON-1 Study of its lead FXR Agonist, EDP-305, for the Treatment of NASH
finance.yahoo.com - September 25 at 8:42 PM
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel